Callan Family Office LLC Buys Shares of 17,193 GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Callan Family Office LLC acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 17,193 shares of the company's stock, valued at approximately $1,344,000.

Several other large investors have also recently added to or reduced their stakes in GEHC. State Street Corp grew its holdings in GE HealthCare Technologies by 7.8% in the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company's stock worth $1,747,101,000 after buying an additional 1,347,114 shares in the last quarter. Geode Capital Management LLC boosted its position in GE HealthCare Technologies by 7.2% during the 3rd quarter. Geode Capital Management LLC now owns 10,977,757 shares of the company's stock worth $1,026,898,000 after acquiring an additional 733,819 shares during the period. Van ECK Associates Corp boosted its position in GE HealthCare Technologies by 107.3% during the 4th quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company's stock worth $378,520,000 after acquiring an additional 2,506,417 shares during the period. Bank of New York Mellon Corp grew its stake in shares of GE HealthCare Technologies by 11.2% in the fourth quarter. Bank of New York Mellon Corp now owns 3,476,586 shares of the company's stock worth $271,800,000 after purchasing an additional 349,539 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of GE HealthCare Technologies by 9.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,959,256 shares of the company's stock valued at $231,355,000 after purchasing an additional 248,318 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Citigroup upped their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research note on Thursday, February 13th. Finally, Wells Fargo & Company raised their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research note on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $97.67.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC traded up $1.17 during trading on Friday, hitting $86.58. The company had a trading volume of 4,075,712 shares, compared to its average volume of 2,984,066. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.80. The business's 50-day moving average is $86.77 and its 200 day moving average is $86.15. The company has a market cap of $39.59 billion, a P/E ratio of 20.00, a PEG ratio of 3.19 and a beta of 1.13. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.